Assay standardization bias: different prostate cancer detection rates and clinical outcomes resulting from different assays for free and total prostate-specific antigen.

Sotelo, Rene J; Mora, K Elias; Pérez, L Hermes; Novoa, John; Carmona, Oswaldo; De Andrade, Robert; Borges, Rafael E; Parada, David; Loeb, Stacy; Catalona, William J

Sotelo, Rene J; Mora, K Elias; Pérez, L Hermes; Novoa, John; Carmona, Oswaldo; De Andrade, Robert; Borges, Rafael E; Parada, David; Loeb, Stacy; Catalona, William J.

Affiliation

Sotelo RJ; Instituto Medico La Floresta, Cauro Foundation, Caracas, Venezuela. renesotelo@cantv.net

Urology ; 69(6): 1143-6, 2007 Jun.

Article in En | MEDLINE | ID: mdl-17572203

Subject(s)

Biological Assay/standards; Prostate-Specific Antigen/blood; Prostatic Neoplasms/blood; Humans; Male; Mass Screening; Middle Aged; Prospective Studies; Prostatic Neoplasms/prevention & control; Sensitivity and Specificity

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Biological Assay / Prostate-Specific Antigen Type of study: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Screening_studies Limits: Humans / Male / Middle aged Language: En Journal: Urology Year: 2007 Document type: Article Affiliation country: Venezuela Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links